Evidence map›Paper›PMID 35694476›Full record

ArticleACS omega2022

Microbial-Catalyzed Baeyer-Villiger Oxidation for 3,4-

Pingping Shen, Jing Zhou, Xuewa Jiang, Haixia Ge, Weiwei Wang, Boyang Yu, Jian Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Pingping ShenState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, P. R. China.
Jing ZhouState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, P. R. China.
Xuewa JiangState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, P. R. China.
Haixia GeSchool of Life Sciences, Huzhou University, Huzhou 313000, P. R. China.ORCID https://orcid.org/0000-0003-3087-457X
Weiwei WangNanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210033, P. R. China.
Boyang YuJiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, P. R. China.
Jian ZhangState Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, P. R. China.ORCID https://orcid.org/0000-0003-3349-0459
China Pharmaceutical University · CNHuzhou University · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pentacyclic triterpenoids are considered to be the potential HMGB1 inhibitors, but due to the limited number of hydrogen bond donors and the number of rotatable bonds in the rigid skeletons, their further chemical biology research with this target was restricted. To improve these profiles, microbial-catalyzed Baeyer-Villiger oxidation of the primary ursane and oleanane-type triterpenoids including uvaol (

Identifiers

PMID35694476
PMCPMC9178611
OpenAlexW4281560137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.